Delivery technologies

Sygnature Discovery launches in vivo inflammation model and includes kidney and neuroinflammation

12-Jun-2023 By Liza Laws

Sygnature Discovery has launched an in vivo inflammation model, that the company says is ‘exciting but only the beginning’ of understanding life-limiting neuroinflammatory conditions.

Owkin invests $50M in spatial omics project that will 'revolutionize cancer research'

08-Jun-2023 By Liza Laws

Artificial intelligence (AI) biotech company, Owkin, has invested $50million in a project that will use spatial omics, a set of cutting-edge technologies that offer unprecedented information on the structure of tumors.

Michael J Fox Foundation chooses platform to help with Parkinson's research

25-May-2023 By Liza Laws

H1, a US data healthcare data technology company has been selected by non-profit funder of Parkinson’s Disease (PD) research, The Michael J Fox Foundation (MJFF), for its Trial Landscape solution.

Cognizant to provide comprehensive approach to adopting AI

16-May-2023 By Liza Laws

Cognizant has announced a platform that can use it consulting, advisory, ecosystem partnership along with digital studios and industry knowledge to help its clients transition to generative artificial intelligence (AI).

One of Germany’s biggest research organizations selects DDN for AI-driven discoveries

11-May-2023 By Liza Laws

Helmholtz Munich, one of Germany’s 19 research centers, that develops future solutions and technologies has selected DataDirect Networks (DDN) to accelerate its artificial intelligence (AI) driven discoveries.

AARDEX Group partners with the Digital Medical Society's new project to improve user needs

10-May-2023 By Liza Laws

AARDEX Group has joined forces with other industry companies to partner with a new project from The Digital Medical Society (DiMe) called Extending the Verification, Analytical Validation, and Clinical Validation – or V3+ Framework.

Health authority approval given to Omya for API production

27-Apr-2023 By Liza Laws

Swiss company Omya’s production site in Kemalpaşa, Turkey, has gained health authority approval to produce GMP-compliant pharmaceutical ingredients.

Greenphire launches app expanding convenience for patients in clinical trials

27-Apr-2023 By Liza Laws

Greenphire, a company that finds solutions for companies wanting to run clinical trials has launched a new patient-facing digital platform.

Self-testing at home kits cut waiting time and ease pressure on health services, 2San says

18-Apr-2023 By Liza Laws

Diagnostic and digital tools company, 2San, has been listed with LLoydsPharmacy to offer seven health tests customers can do at home.

Interview: How to avoid unnecessary legwork and data scraping with Aerona's modern approach across pharma divisions

18-Apr-2023 By Liza Laws

Aerona Clinical is a medium sized pharmaceutical company, represented not only in the United Kingdom, but in Europe, and with a global reach. The company has been operating in this environment in the pharma industry for 15 to 20 years.

Taros and Welab combine to provide discovery and development services

17-Apr-2023 By Ben Hargreaves

The German and Spanish companies use their relevant expertise in conjunction to provide clients with services spanning from hit generation to pre-clinical development.

Meridian sets down $100m for US manufacturing facility

17-Apr-2023 By Ben Hargreaves

Only a few months after being bought out, the CDMO invests in its capabilities with a facility to support drug-device products and sterile fill-finish.

University becomes Freenome's study partner for multi-cancer screening approach

13-Apr-2023 By Liza Laws

The Institute for Population and Precision Health (IPPH) at the University of Chicago has joined private biotech company, Freenome, to become its partner as part of a study.

Boehringer Ingelheim, Cognizant and Veeva connect using 'technology ecosystem'

13-Apr-2023 By Liza Laws

Unifying medicinal development processes and data within a connected technology ecosystem will enhance collaboration, two partnering companies using a development cloud have said.

Phlow raises funds to expand its CDMO capabilities

12-Apr-2023 By Ben Hargreaves

The CDMO completes a Series B capital raise, and it will use the funds generated to broaden its commercial offerings through its cdmoX program.

Breakthrough that could put an end to invasive surgery for rectal cancer patients

12-Apr-2023 By Liza Laws

A breakthrough in rectal cancer treatment has been discovered through a collaboration between a cancer intelligence company and the world’s largest and oldest cancer center. It could put an end to the invasive surgery patients may have faced.

FDA grants approval for OTC opioid overdose treatment

03-Apr-2023 By Ben Hargreaves

The naloxone hydrochloride nasal spray will be made available over-the-counter, therefore not requiring a prescription, in an effort to reduce deaths from opioid abuse.

Cingulate and Indegene announce agreement for lead ADHD drug - the first of its kind

31-Mar-2023 By Liza Laws

An agreement has been reached to promote Cingulate Inc’s ‘first true entire active day medication’ designed to treat attention deficit hyperactivity disorder (ADHD).

Greenphire introduces new tech for patient communities and expands deal with Merck

30-Mar-2023 By Liza Laws

In its bid to what it says will make participation in clinical trials easier and more sustainable, Greenphire has revealed a patient-powered registry and it has also expanded a deal with Merck.

Hovione and Laxxon partner on 3D printed pharmaceuticals

27-Mar-2023 By Ben Hargreaves

The two companies enter into a long-term partnership to advance 3D screen printing technologies for applications within the pharma industry.

AbbVie receives CRL over drug delivery device

27-Mar-2023 By Ben Hargreaves

The US FDA demanded more information about the device, which would deliver ABBV-951 to patients, should the treatment be approved.

Powerful tool for capturing aneurysms from Viz.ai given funding and FDA clearance

23-Mar-2023 By Liza Laws

A powerful tool that could capture abdominal aortic aneurysms (AAA) and refer those at risk is the first to be given clearance by the US Food and Drink Administration (FDA).

Zebra adds new environmental sensors for pharma supply chain

23-Mar-2023 By Ben Hargreaves

The company launches its new ZS300 sensor, ZB200 bridge and Android sensor discovery app, which will be made available for use with the supply chains of the pharma and food industries.

Drug discovery timelines accelerated as Iktos develops AI and drug capabilities with series A funding

21-Mar-2023 By Liza Laws

Iktos, a company specializing in artificial intelligence (AI) for new drug discovery has closed a €15.5 million series A funding round.

EDSA outlines supply danger to 100 medicines after manufacturer bankruptcy

20-Mar-2023 By Ben Hargreaves

Earlier this year, Akorn Pharmaceuticals fell into bankruptcy, and now an alliance of stakeholders have released a report outlining potential supply disruption to a number of medications.

Bluepharma invests €30M in industrial unit for oncology drugs

20-Mar-2023 By Liza Laws

Portuguese pharma company, Bluepharma, has opened an industrial unit specializing in producing oral solid, high potent drugs in the oncology area.

CatSci Ltd and AGC Pharma Chemicals announce their strategic partnership

16-Mar-2023 By Liza Laws

Medicine developer, CatSci Ltd announced yesterday (March 15) that it has formed a new partnership with AGC Pharma Chemicals, a small molecule Contract Development and Manufacturing Organisation (CDMO).

Genixus adds manufacturing facility for syringe production

16-Mar-2023 By Ben Hargreaves

The company will build out a manufacturing, warehousing, and distribution center in the US to expand capacity for syringes.

Charité and Exscientia collaboration to use AI to advance blood cancer treatment

09-Mar-2023 By Liza Laws

Charité – Universitätsmedizin Berlin, one of Europe’s largest university hospitals is collaborating with UK-based Exscientia to make use of an artificial intelligence-driven precision medicine platform in haematological cancers.

Interview: Tarquin Scadding-Hunt, CEO, mdgroup - the challenges of patient recruitment and retention

08-Mar-2023 By Liza Laws

Patient recruitment and retention is an ongoing issue for everyone working in the clinical trials field. Over recent weeks, OSP has interviewed or spoken to a number of companies about their solutions.

Decentralized Trials

Greater digital biomarklers adoption in clinical studies as Koneksa and SSI Strategy collaborate

08-Mar-2023 By Ben Hargreaves

The two partners will pool capabilities to provide an expanded service to their clients, which will see Koneksa provide its digital biomarkers tools and SSI Strategy its expertise in drug development.

Participants in HCM trial tracked using Vivalink's biometric data platform

08-Mar-2023 By Ben Hargreaves

UC San Francisco will conduct a six-month clinical trial on hypertrophic cardiomyopathy, which will rely on feedback from Vivalink’s biometric data platform.

Syneos Health announces creation of DCT site network to 'realize meaningful momentum' for customers and partners

08-Mar-2023 By Ben Hargreaves

The company establishes a network across North America that will cover various therapeutic areas, including cardiology and oncology.

TandemAI gets rolling with $35m in financing

07-Mar-2023 By Ben Hargreaves

The Chinese company is working on a drug discovery platform utilizing AI, and managed to secure funds to progress its business.

News in brief: Greenphire's ConneX 'supports trial retention'

07-Mar-2023 By Liza Laws

A clinical trial travel solution that can remove administrative burdens for research sites and eliminate logistical and financial barriers for participants has significantly expanded.

SCOPE 2023

Double win for StudyKIK's oncology and cash apps helping trial patients

02-Mar-2023 By Liza Laws

Year on year, the SCOPE summit brings thousands of people working in the pharma field together and the last one attracted more than 2,300 leaders in clinical operations and research.

ObvioHealth reveals new multitasking digital therapeutics API

23-Feb-2023 By Liza Laws

With the ongoing digital shift in clinical trials, companies are continuously striving to improve both patient experience and clinical data quality.

AZ blames UK tax for Ireland API plant decision

13-Feb-2023 By Ben Hargreaves

The company’s CEO stated that a ‘discouraging tax rate’ was behind the decision to build a $360m API plant in Ireland rather than the UK.

Biogen licenses subcutaneous drug delivery system for neurological drugs

12-Jan-2023 By Ben Hargreaves

Biogen partners with Alcyone to gain access to ThecaFlex, which is able to deliver therapies into the intrathecal space.

BioNTech links up with Ryvu on small molecule immunotherapy

06-Dec-2022 By Ben Hargreaves

BioNTech and Ryvu Therapeutics will collaborate to develop oncology programs, with the pair announcing that they will work together as part of a multi-target research collaboration.

Mallinckrodt applies to FDA for inhaled nitric oxide delivery system

10-Oct-2022 By Ben Hargreaves

The company announces the submission of a 510(k) premarket notification application for its investigational inhaled nitric oxide delivery system for its INOmax gas product.

Swimming algae microrobots deliver antibiotic nanoparticles to lungs

03-Oct-2022 By Ben Hargreaves

Researchers from the University of California San Diego tested whether algae could improve the delivery of antibiotics to treat cases of bacterial pneumonia.

TransCelerate CEO: Speeding drug development a ‘win-win’ for all concerned

28-Sep-2022

TransCelerate BioPharma continues to work towards “bringing new medicines to patients faster”. We caught up with the organization’s CEO to hear about its main achievements over the past decade and learn about what comes next.

Intranasal TIPs therapy study shows potential to reduce COVID-19 transmission

19-Sep-2022 By Maggie Lynch

Gladstone Institutes seek FDA approval for human clinical trial after single-dose, intranasal TIPs treatment for SARS-CoV-2 infection limits transmission in infected animals by decreased viral shedding.

Precision delivery device offers hope for menstrual migraine patients

08-Sep-2022 By Jenni Spinner

Impel Pharmaceuticals’ Trudhesa treatment, paired with its Precision Olfactory Delivery system, reportedly shows promise to women suffering from the condition.

Vaderis exits stealth as ex-Almac Discovery candidate enters clinical development

07-Sep-2022 By Nick Taylor

The clinical-stage biotechnology company is working on the advancement of a treatment for a blood vessel disorder that it licensed from the other company

Sanofi strikes $20m AI drug discovery deal with Atomwise

07-Sep-2022 By Nick Taylor

The pharma company’s collaboration with the drug discovery specialist involves using artificial intelligence to discover and develop up to five drug targets.

People on the Move: September 2022

01-Sep-2022 By Jenni Spinner

This month’s announcements of appointments, acquisitions, new hires, and other news include Standigm, Astellas Pharma, Trialbee, and other key companies.

Lonza expanding dry powder inhalation capabilities at Florida site

01-Sep-2022 By Jenni Spinner

In response to rising demand for inhalable treatments geard toward respiratory conditions, the company is adding capabilities and capacity at its Tampa site.

Market demands, trends impacting APIs and excipients: MilliporeSigma

31-Aug-2022 By Jenni Spinner

An expert from the company discusses how ever-changing patient needs and other dynamic factors are likely to impact pharma ingredient trends down the road.